MESO Competitors & Alternatives
Compare Mesoblast Ltd with similar stocks in the same industry
Biotechnology
MESO
Main Stock$15.48
Tradestie Score
47
Market Cap
$2.08B
Revenue Growth
3.9%
Analyst Upside
+139.0%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$66.17
|
$2.21B | - | 48 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$21.09
|
$2.18B | - | 45 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$20.45
|
$2.02B | - | 34 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.74
|
$2.01B | - | 32 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$33.41
|
$1.97B | - | 54 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$10.49
|
$1.92B | - | 51 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$83.45
|
$1.92B | - | 39 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$66.74
|
$1.90B | 49.2 | 70 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$35.05
|
$1.84B | - | 33 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.60
|
$1.81B | - | 33 | Compare |
More MESO Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2836)
237 stocks in this industry